Pier Pasquale Leone, Samantha Sartori, Jonathan Murphy, Kenneth Smith, Angelo Oliva, Mauro Gitto, Benjamin Bay, Anastasios Roumeliotis, Birgit Vogel, David Power, Anton Camaj, Francesca Maria Di Muro, Annapoorna Kini, Samin Sharma, Roxana Mehran, George Dangas
{"title":"Clinical Outcomes After Percutaneous Coronary Intervention for Left Main Coronary Artery Disease in Patients of Diverse Race/Ethnicity.","authors":"Pier Pasquale Leone, Samantha Sartori, Jonathan Murphy, Kenneth Smith, Angelo Oliva, Mauro Gitto, Benjamin Bay, Anastasios Roumeliotis, Birgit Vogel, David Power, Anton Camaj, Francesca Maria Di Muro, Annapoorna Kini, Samin Sharma, Roxana Mehran, George Dangas","doi":"10.1016/j.amjcard.2024.10.002","DOIUrl":null,"url":null,"abstract":"<p><p>Data on percutaneous coronary intervention (PCI) for left main coronary artery (LMCA) disease in patients of diverse race/ethnicity are scant. This study aimed to assess the impact of race/ethnicity on clinical outcomes at 12-month follow-up of patients with LMCA disease who underwent PCI with drug-eluting stent implantation. All patients who underwent PCI for LMCA disease between 2010 and 2019 at a tertiary care center were prospectively enrolled. Clinical outcomes were assessed per each race/ethnic group. The primary end point was the composite of all-cause death, myocardial infarction, or stroke at 12 months. A total of 774 consecutive patients with known race/ethnicity were prospectively enrolled (62.1% [n = 481] Caucasian, 17.2% [n = 133] Hispanic, 12.7% [n = 98] Asian, and 8.0% [n = 62] African-American). Compared with Caucasians, the hazard rate of the primary end point tended to be lower in Asian patients (6.1% vs 14.2%; hazard ratio [HR] 0.41, 95% confidence interval [CI] 0.16 to 1.03) and similar in African-American (13.7% vs 14.2%; HR 0.93, 95% CI 0.40 to 2.16) and Hispanic patients (14.2% vs 14.2%; HR 1.02, 95% CI 0.58 to 1.78). Hazard rates of target vessel or lesion revascularization were comparable among the 4 groups. Cox multivariable regression adjustment confirmed consistent findings and revealed higher hazard rates of postdischarge bleeding in African-Americans compared with Caucasians (HR 5.89, 95% CI 1.00 to 34.5). In conclusion, within a racially/ethnically diverse cohort of patients who underwent PCI for LMCA disease, when compared with Caucasians, Asians had lower risk of all-cause death, myocardial infarction, or stroke, whereas African-Americans had increased risk of postdischarge bleeding. Condensed abstract Evidence on percutaneous coronary intervention for left main coronary artery disease in patients of diverse race/ethnicity is limited. Among 774 consecutively enrolled patients from diverse racial/ethnic backgrounds, Asians tended to experience a lower hazard for all-cause death, myocardial infarction, or stroke compared with Caucasians. A higher hazard rate of postdischarge bleeding was observed in African-Americans compared with Caucasians. Further dedicated prospective studies enrolling racial/ethnic minorities are needed to confirm the presence of effect modification in clinical outcomes based on racial/ethnic background.What is knownWhat the study adds.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.amjcard.2024.10.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0
Abstract
Data on percutaneous coronary intervention (PCI) for left main coronary artery (LMCA) disease in patients of diverse race/ethnicity are scant. This study aimed to assess the impact of race/ethnicity on clinical outcomes at 12-month follow-up of patients with LMCA disease who underwent PCI with drug-eluting stent implantation. All patients who underwent PCI for LMCA disease between 2010 and 2019 at a tertiary care center were prospectively enrolled. Clinical outcomes were assessed per each race/ethnic group. The primary end point was the composite of all-cause death, myocardial infarction, or stroke at 12 months. A total of 774 consecutive patients with known race/ethnicity were prospectively enrolled (62.1% [n = 481] Caucasian, 17.2% [n = 133] Hispanic, 12.7% [n = 98] Asian, and 8.0% [n = 62] African-American). Compared with Caucasians, the hazard rate of the primary end point tended to be lower in Asian patients (6.1% vs 14.2%; hazard ratio [HR] 0.41, 95% confidence interval [CI] 0.16 to 1.03) and similar in African-American (13.7% vs 14.2%; HR 0.93, 95% CI 0.40 to 2.16) and Hispanic patients (14.2% vs 14.2%; HR 1.02, 95% CI 0.58 to 1.78). Hazard rates of target vessel or lesion revascularization were comparable among the 4 groups. Cox multivariable regression adjustment confirmed consistent findings and revealed higher hazard rates of postdischarge bleeding in African-Americans compared with Caucasians (HR 5.89, 95% CI 1.00 to 34.5). In conclusion, within a racially/ethnically diverse cohort of patients who underwent PCI for LMCA disease, when compared with Caucasians, Asians had lower risk of all-cause death, myocardial infarction, or stroke, whereas African-Americans had increased risk of postdischarge bleeding. Condensed abstract Evidence on percutaneous coronary intervention for left main coronary artery disease in patients of diverse race/ethnicity is limited. Among 774 consecutively enrolled patients from diverse racial/ethnic backgrounds, Asians tended to experience a lower hazard for all-cause death, myocardial infarction, or stroke compared with Caucasians. A higher hazard rate of postdischarge bleeding was observed in African-Americans compared with Caucasians. Further dedicated prospective studies enrolling racial/ethnic minorities are needed to confirm the presence of effect modification in clinical outcomes based on racial/ethnic background.What is knownWhat the study adds.